"Ozempic? Back then, Ozempic was not part of the common lexicon. But quietly, in certain circles, this injectable drug, which is licensed for the treatment of type 2 diabetes, was being prescribed privately and off-label for weight loss. Flash forward to today and the picture is vastly different. "So many fashion people are on it," she tells me today. "And now they're very vocal." Serena Williams, Elon Musk and Whoopi Goldberg have all spoken about using weight-loss injections."
"Thousands of NHS patients are believed to be missing out. And with the NHS tightly restricting access, some working in the field warn a two-tier system around weight-loss drugs is developing - one that's benefitting the most well-off. Martin Fidock, who is UK managing director of Ovivia, which provides Wegovy and lifestyle support to NHS patients, claims that thanks to varying thresholds of eligibility in different regions, NHS prescriptions are a "postcode lottery"."
Injectable diabetes drugs such as Ozempic have been repurposed privately for weight loss and have become widely used beyond clinical indications. High-profile figures have publicly used weight-loss injections, and some formulations like Wegovy and Mounjaro are now prescribed on the NHS. Hundreds of thousands of prescriptions remain tightly restricted by region, leaving thousands of eligible NHS patients without access. Varying eligibility thresholds across regions create a "postcode lottery" for NHS prescriptions, according to Martin Fidock, UK managing director of Ovivia. An estimated 1.5 million people in the UK use these drugs, and more than nine in ten users are believed to pay privately.
Read at www.bbc.com
Unable to calculate read time
Collection
[
|
...
]